Funding for this research was provided by:
University of Western Australia
Article History
Accepted: 16 February 2022
First Online: 14 March 2022
Declarations
:
: Open Access funding enabled and organized by CAUL and its Member Institutions.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable
: All authors contributed to the drafting and editing of the review, as well as subsequent revisions.
: NCW: none. DCC: none. GFW: reports funding or honoraria from Amgen, Pfizer, Esperion, Arrowhead, Regeneron, Sanofi, AstraZeneca, Novartis.